FDA – SEC ACTIONS

Director Fails to Disclose FDA Orders Halting Two Drugs

Posted on December 04, 2024 by T. Gorman Posted in SECActions

It is axiomatic firms must disclose of material information that is complete and accurate. Thus, for example, when the president of a regulated entity speaks to investors regarding communications with the firm’s regulator, it is critical that the information about …

Director Fails to Disclose FDA Orders Halting Two Drugs

Tagged with: disclosure, FDA, SEC

SEC Charges Medical Device Company and its Founder with Fraud

Posted on June 26, 2013 by T. Gorman Posted in SECActions

The SEC charged a medical device company and its founder with making false statements about a FDA approval for a key product.

Search SEC Actions

Prepared:

Tag: FDA

Director Fails to Disclose FDA Orders Halting Two Drugs

SEC Charges Medical Device Company and its Founder with Fraud